Trademark Overview
On Monday, October 21, 2024, a trademark application was filed for WAYBRI with the United States Patent and Trademark Office. The USPTO has given the WAYBRI trademark a serial number of 98812003. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, October 21, 2024. This trademark is owned by Edgewise Therapeutics, Inc.. The WAYBRI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of neuromuscular and cardiac disorders and diseases; anti-inflammatories